{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:32:45Z","timestamp":1793370765230,"version":"4.5.0"},"reference-count":295,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.chest.2022.07.025","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:05:32Z","timestamp":1660194332000},"page":"e207-e243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":448,"title":["Perioperative Management of Antithrombotic Therapy"],"prefix":"10.1016","volume":"162","author":[{"given":"James D.","family":"Douketis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Arcelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Dager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiz A.","family":"Fargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Marc","family":"Samama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahrish H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso J.","family":"Tafur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang V.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Moores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jth.13305","article-title":"Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery","volume":"14","author":"Spyropoulos","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib2","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s11606-020-05904-0","article-title":"Oral anticoagulant utilization in the United States and United Kingdom","volume":"35","author":"Colacci","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bjs.10643","article-title":"Population-based incidence rate of inpatient and outpatient surgical procedures in a high-income country","volume":"105","author":"Omling","year":"2018","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib4","first-page":"68","article-title":"Prior authorization and Canadian public utilization of direct-acting oral anticoagulants","volume":"13","author":"Gao","year":"2017","journal-title":"Healthc Policy"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib5","first-page":"722","article-title":"\u2018Real-world\u2019 atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase","volume":"19","author":"Proietti","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.chest.2022.07.025_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2017.08.011","article-title":"International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries","volume":"194","author":"Steinberg","year":"2017","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib7","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.amjcard.2017.08.014","article-title":"Temporal trends in the incidence, prevalence, and survival of patients with atrial fibrillation from 2004 to 2016","volume":"120","author":"Williams","year":"2017","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial","volume":"126","author":"Healey","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13070","article-title":"Epidemiology of atrial fibrillation","volume":"72","author":"Zulkifly","year":"2018","journal-title":"Int J Clin Pract"},{"issue":"18","key":"10.1016\/j.chest.2022.07.025_bib10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.005754","volume":"129","author":"Sherwood","year":"2014","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.chest.2022.07.025_bib11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu285","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703","article-title":"Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery","volume":"3","author":"Cruden","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"suppl 6","key":"10.1016\/j.chest.2022.07.025_bib13","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"issue":"suppl 2","key":"10.1016\/j.chest.2022.07.025_bib14","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib15","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/jth.13136","article-title":"Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: reply","volume":"13","author":"Barnes","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.chest.2022.07.025_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.thromres.2019.08.007","article-title":"Structure and function of a perioperative anticoagulation management clinic","volume":"182","author":"Spencer","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib17","first-page":"173","article-title":"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy\": Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of Performance","volume":"46","author":"Dager","year":"2020","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.14-0824","article-title":"Methodologies for the development of CHEST guidelines and expert panel reports","volume":"146","author":"Lewis","year":"2014","journal-title":"Chest"},{"issue":"suppl 2","key":"10.1016\/j.chest.2022.07.025_bib19","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jcin.2014.06.014","article-title":"Direct oral anticoagulants: new drugs and new concepts","volume":"7","author":"Levy","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"31","key":"10.1016\/j.chest.2022.07.025_bib21","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.2174\/138161210793563338","article-title":"Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management","volume":"16","author":"Douketis","year":"2010","journal-title":"Current Pharm Des"},{"issue":"suppl 3","key":"10.1016\/j.chest.2022.07.025_bib22","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.chest.2022.07.025_bib23","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates","volume":"126","author":"Siegal","year":"2012","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.chest.2022.07.025_bib24","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrcardio.2017.223","article-title":"Reversal agents for non-vitamin K antagonist oral anticoagulants","volume":"15","author":"Levy","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.chest.2022.07.025_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2016.01.004","article-title":"Urgent surgery or procedures in patients taking dabigatran or warfarin: analysis of perioperative outcomes from the RE-LY trial","volume":"139","author":"Douketis","year":"2016","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jth.13227","article-title":"When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"14","author":"Levy","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9343(00)00440-X","article-title":"Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation","volume":"109","author":"Pearce","year":"2000","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-134-6-200103200-00011","article-title":"Warfarin therapy for an octogenarian who has atrial fibrillation","volume":"134","author":"Gage","year":"2001","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.chest.2022.07.025_bib32","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1378\/chest.127.1.53","article-title":"Thromboembolic and bleeding complications following St. Jude medical valve replacement: results of the German Experience with Low-Intensity Anticoagulation Study","volume":"127","author":"Hering","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.athoracsur.2004.08.067","article-title":"A\u00a010-year experience with the Carbomedics cardiac prosthesis","volume":"79","author":"Tominaga","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"22","key":"10.1016\/j.chest.2022.07.025_bib36","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1001\/archinte.160.22.3431","article-title":"Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3\u00a0months of anticoagulant therapy","volume":"160","author":"Douketis","year":"2000","journal-title":"Arch Intern Med"},{"issue":"23 suppl 1","key":"10.1016\/j.chest.2022.07.025_bib37","first-page":"14","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"9465","key":"10.1016\/j.chest.2022.07.025_bib38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(05)71880-8","article-title":"Deep vein thrombosis","volume":"365","author":"Kyrle","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cjca.2017.12.012","article-title":"2018 Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy","volume":"34","author":"Mehta","year":"2018","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11910-020-01033-7","article-title":"Perioperative stroke","volume":"20","author":"Leary","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/HCO.0000000000000798","article-title":"Temporal improvements in perioperative stroke rates following coronary artery bypass grafting","volume":"35","author":"Weiss","year":"2020","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib43","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2010.03781.x","article-title":"Risk of stroke after surgery in patients with and without chronic atrial fibrillation","volume":"8","author":"Kaatz","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11739-021-02866-x","article-title":"Perioperative management of antithrombotic therapy: a case-based narrative review","volume":"17","author":"Chen","year":"2022","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.mcna.2020.02.005","article-title":"Periprocedural management of oral anticoagulation","volume":"104","author":"Shaw","year":"2020","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.01.007","article-title":"Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis","volume":"124","author":"Jamula","year":"2009","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib47","first-page":"41","article-title":"Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis","volume":"75","author":"Nematullah","year":"2009","journal-title":"J\u00a0Can Dent Assoc"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib48","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1378\/chest.09-2603","article-title":"Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis","volume":"138","author":"Jamula","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/bjd.13362","article-title":"Perioperative management of and recommendations for antithrombotic medications in dermatological surgery","volume":"172","author":"Palamaras","year":"2015","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib50","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1538-7836.2008.03080.x","article-title":"Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide","volume":"6","author":"Jamula","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib51","first-page":"225","volume":"43","author":"Narouze","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib52","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1213\/ANE.0b013e318251daed","article-title":"The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group Research Consortium","volume":"116","author":"Bateman","year":"2013","journal-title":"Anesth Analg"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib53","first-page":"687","article-title":"Dental management of patients on direct oral anticoagulants: case series and literature review","volume":"47","author":"Abayon","year":"2016","journal-title":"Quintessence Int"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mcna.2018.08.003","article-title":"Colonoscopy, polypectomy, and the risk of bleeding","volume":"103","author":"Feagins","year":"2019","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10029-004-0245-2","article-title":"An updated traditional classification of inguinal hernias","volume":"8","author":"Zollinger","year":"2004","journal-title":"Hernia"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib56","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","article-title":"Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin","volume":"110","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib57","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1016\/S1470-2045(19)30750-8","article-title":"2019 International clinical practice guidelines for the treatment of venous thromboembolism\u2014authors\u2019 reply","volume":"20","author":"Douketis","year":"2019","journal-title":"Lancet Oncol"},{"issue":"suppl 1","key":"10.1016\/j.chest.2022.07.025_bib58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/00325481.2021.1891751","article-title":"Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery","volume":"133","author":"D\u2019Astous","year":"2021","journal-title":"Postgrad Med"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/21548331.2018.1420346","article-title":"Evaluating the role of clinical pharmacists in pre-procedural anticoagulation management","volume":"46","author":"Kataruka","year":"2018","journal-title":"Hosp Pract (1995)"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bpa.2020.05.001","article-title":"Telemedicine for preoperative assessment during a COVID-19 pandemic: recommendations for clinical care","volume":"34","author":"Mihalj","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2016.04.042","article-title":"Management of periprocedural anticoagulation: a survey of contemporary practice","volume":"68","author":"Flaker","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rth2.12430","article-title":"A\u00a0physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant","volume":"5","author":"Douketis","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11239-018-1625-2","article-title":"Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulation","volume":"45","author":"Kurlander","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib64","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/STROKEAHA.110.611905","article-title":"Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence","volume":"42","author":"Broderick","year":"2011","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.hrthm.2014.03.006","article-title":"Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial","volume":"11","author":"Steinberg","year":"2014","journal-title":"Heart Rhythm"},{"issue":"7652","key":"10.1016\/j.chest.2022.07.025_bib66","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2022.07.025_bib67","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2022.07.025_bib68","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7001","key":"10.1016\/j.chest.2022.07.025_bib69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"suppl 6","key":"10.1016\/j.chest.2022.07.025_bib70","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","article-title":"Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations","volume":"30","author":"Palareti","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib72","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2165\/00003088-200544120-00003","article-title":"Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol","volume":"44","author":"Ufer","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib73","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1365-2141.2002.03493.x","article-title":"Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon","volume":"117","author":"Gadisseur","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-135-6-200109180-00008","article-title":"Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin","volume":"135","author":"Hylek","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.chest.2022.07.025_bib75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.med.070808.170037","article-title":"Pharmacogenetics of warfarin","volume":"61","author":"Kamali","year":"2010","journal-title":"Annu Rev Med"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib76","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib77","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMra062668","article-title":"Perioperative stroke","volume":"356","author":"Selim","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","article-title":"Temporary discontinuation of warfarin therapy: changes in the international normalized ratio","volume":"122","author":"White","year":"1995","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib79","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2009.03685.x","article-title":"Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?","volume":"8","author":"Steib","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib80","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1055\/s-0038-1645856","article-title":"Peri-operative adverse outcomes in patients with atrial fibrillation taking warfarin or edoxaban: analysis of the ENGAGE AF-TIMI 48 Trial","volume":"118","author":"Douketis","year":"2018","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"issue":"5-6","key":"10.1016\/j.chest.2022.07.025_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000446406","article-title":"Risk of ischemic stroke in high risk atrial fibrillation patients during periods of warfarin discontinuation for surgical procedures","volume":"42","author":"Qureshi","year":"2016","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib83","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1742-1241.2006.01081.x","article-title":"Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients who require\u00a0colonoscopy or gastroscopy","volume":"61","author":"Constans","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib84","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.thromres.2009.01.011","article-title":"Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients","volume":"124","author":"Daniels","year":"2009","journal-title":"Thromb Res"},{"issue":"25","key":"10.1016\/j.chest.2022.07.025_bib85","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2014-08-595496","article-title":"Management and clinical outcomes in patients treated with apixaban vs\u00a0warfarin undergoing procedures","volume":"124","author":"Garcia","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib86","first-page":"285","article-title":"Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry","volume":"16","author":"Hammerstingl","year":"2007","journal-title":"J\u00a0Heart Valve Dis"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1538-7836.2009.03649.x","article-title":"Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin","volume":"8","author":"Malato","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"22","key":"10.1016\/j.chest.2022.07.025_bib88","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/CIRCULATIONAHA.108.823211","article-title":"Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study","volume":"119","author":"Pengo","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib89","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/jama.1978.03280350062016","article-title":"Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations","volume":"239","author":"Tinker","year":"1978","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib90","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1345\/aph.10305","article-title":"Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis","volume":"35","author":"Tinmouth","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib91","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1538-7836.2009.03598.x","article-title":"Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy","volume":"7","author":"Witt","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib92","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0025-6196(11)60891-4","article-title":"Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation","volume":"83","author":"Wysokinski","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib93","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9149(99)00341-0","article-title":"Use of enoxaparin for the chronically anticoagulated patient before and after procedures","volume":"84","author":"Spandorfer","year":"1999","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib94","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1592\/phco.24.6.649.34740","article-title":"A\u00a0disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation","volume":"24","author":"Spyropoulos","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib95","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib96","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/bjs.5835","article-title":"Prevention of perioperative thromboembolism in patients with atrial fibrillation","volume":"94","author":"Beldi","year":"2007","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib97","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12613","article-title":"Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial","volume":"12","author":"Schulman","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib98","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11239-017-1553-6","article-title":"A\u00a0randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure","volume":"44","author":"Bungard","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11239-007-0022-z","article-title":"Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin","volume":"24","author":"Woods","year":"2007","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4065\/76.3.260","article-title":"Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy","volume":"76","author":"Shields","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib101","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1345\/aph.1R497","article-title":"Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute\/critical care setting","volume":"46","author":"Tsu","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib102","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1177\/1060028021993239","article-title":"INR response to low-dose vitamin K in warfarin patients","volume":"55","author":"Kulig","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib103","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/trf.15146","article-title":"Effect of vitamin K administration on rate of warfarin reversal","volume":"59","author":"Polito","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib104","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1537-2995.2012.03755.x","article-title":"Clinical experience with oral versus intravenous vitamin K for warfarin reversal","volume":"53","author":"Meehan","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.chest.2022.07.025_bib105","doi-asserted-by":"crossref","first-page":"n1205","DOI":"10.1136\/bmj.n1205","article-title":"Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial","volume":"373","author":"Kovacs","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib106","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.114.011777","article-title":"Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"131","author":"Steinberg","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib107","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2009.06.065","article-title":"Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation","volume":"104","author":"Bui","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib108","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.89.5.527","article-title":"Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol","volume":"89","author":"Ferreira","year":"2003","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib109","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.amjcard.2008.05.042","article-title":"Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)","volume":"102","author":"Spyropoulos","year":"2008","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH14-04-0305","article-title":"Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial","volume":"113","author":"Douketis","year":"2015","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib111","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/jth.14903","article-title":"Periprocedural bridging anticoagulation in patients with venous thromboembolism: a registry-based cohort study","volume":"18","author":"Barnes","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib112","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/ATVBAHA.109.199406","article-title":"Periprocedural anticoagulation management of patients with venous thromboembolism","volume":"30","author":"McBane","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib113","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamainternmed.2015.1843","article-title":"Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures","volume":"175","author":"Clark","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib114","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/annonc\/mds058","article-title":"Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients","volume":"23","author":"Tafur","year":"2012","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib115","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/j.1538-7836.2012.04907.x","article-title":"Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study","volume":"10","author":"Skeith","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib116","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.amjmed.2016.05.002","article-title":"Periprocedural anticoagulation management of patients with thrombophilia","volume":"129","author":"Wysokinska","year":"2016","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib117","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.amjmed.2019.01.004","article-title":"Periprocedural bridging in patients with venous thromboembolism: a systematic review","volume":"132","author":"Baumgartner","year":"2019","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib118","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jama.279.6.458","article-title":"Risk of fatal pulmonary embolism in patients with treated venous thromboembolism","volume":"279","author":"Douketis","year":"1998","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib119","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1538-7836.2005.01674.x","article-title":"Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes","volume":"3","author":"Halbritter","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-005-3120-9","article-title":"Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol","volume":"20","author":"Jaffer","year":"2005","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib121","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12872-017-0719-7","article-title":"Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis","volume":"17","author":"Yong","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib122","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11239-012-0787-6","article-title":"Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients","volume":"35","author":"Attaya","year":"2013","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib123","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0030-4220(93)90401-O","article-title":"Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy","volume":"75","author":"Borea","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib124","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1054\/bjom.2001.0773","article-title":"Can warfarin be continued during dental extraction? Results of a randomized controlled trial","volume":"40","author":"Evans","year":"2002","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1538-7836.2006.01762.x","article-title":"Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets","volume":"4","author":"Sacco","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib126","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.joms.2002.12.001","article-title":"Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery","volume":"61","author":"Al-Belasy","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib127","first-page":"504","article-title":"Tranexamic acid mouthwash\u2014a prospective randomized study of a 2-day regimen vs\u00a05-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions","volume":"32","author":"Carter","year":"2003","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib128","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.joms.2003.01.001","article-title":"Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study","volume":"61","author":"Carter","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1067\/moe.2001.115463","article-title":"Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants","volume":"92","author":"Halfpenny","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0278-2391(10)80291-5","article-title":"Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants","volume":"51","author":"Ramstrom","year":"1993","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib131","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.joms.2008.12.027","article-title":"Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth","volume":"67","author":"Bajkin","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib132","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1834-7819.2003.tb00019.x","article-title":"Minor oral surgical procedures in patients on oral anticoagulants\u2014a controlled study","volume":"48","author":"Cannon","year":"2003","journal-title":"Aust Dent J"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib133","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0266-4356(98)90177-2","article-title":"Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary?","volume":"36","author":"Devani","year":"1998","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib134","first-page":"375","article-title":"Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication","volume":"28","author":"Gaspar","year":"1997","journal-title":"Quintessence Int"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib135","first-page":"315","article-title":"Dental procedures in patients receiving oral anticoagulation therapy","volume":"3","author":"Saour","year":"1994","journal-title":"J\u00a0Heart Valve Dis"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib136","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5694\/j.1326-5377.1990.tb126293.x","article-title":"Use of tranexamic acid mouthwash in dental procedures in patients taking oral anticoagulants","volume":"153","author":"Street","year":"1990","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib137","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001721-200301000-00006","article-title":"Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol","volume":"14","author":"Zanon","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib138","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1054\/ijom.2001.0172","article-title":"Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding","volume":"30","author":"Blinder","year":"2001","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib139","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0278-2391(03)00727-4","article-title":"Prevention of postoperative bleeding in anticoagulated patients undergoing oral surgery: use of platelet-rich plasma gel","volume":"61","author":"Della Valle","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0030-4220(90)90139-J","article-title":"Dental extraction for patients on oral anticoagulant therapy","volume":"70","author":"Martinowitz","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib141","first-page":"13","article-title":"Minor oral surgery in anticoagulated patients: local measures alone are sufficient for haemostasis","volume":"27","author":"Ramli","year":"2005","journal-title":"Singapore Dental J"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib142","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/107602960000600208","article-title":"Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedures","volume":"6","author":"Russo","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib143","first-page":"713","article-title":"Postextraction hemostasis in patients on anticoagulant therapy: the use of a fibrin sealant","volume":"23","author":"Zusman","year":"1992","journal-title":"Quintessence Int"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib144","first-page":"77","article-title":"Prevention of postoperative bleeding in patients taking oral anticoagulants. Effects of tranexamic acid [in French]","volume":"104","author":"Keiani Motlagh","year":"2003","journal-title":"Rev Stomatol Chir Maxillofac"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib145","first-page":"69","article-title":"Protocol for adapting treatment with vitamin K antagonists before dental extraction [in French]","volume":"104","author":"Garcia-Darennes","year":"2003","journal-title":"Rev Stomatol Chir Maxillofac"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib146","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.joms.2007.06.655","article-title":"Hemostatic management of tooth extractions in patients on oral antithrombotic therapy","volume":"66","author":"Morimoto","year":"2008","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib147","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0278-2391(00)90324-0","article-title":"Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered?","volume":"58","author":"Campbell","year":"2000","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib148","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1079-2104(98)90367-5","article-title":"Efficacy of fibrin sealant in patients on various levels of oral anticoagulant undergoing oral surgery","volume":"86","author":"Bodner","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.chest.2022.07.025_bib149","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fphar.2019.00866","article-title":"Bleeding risk in patients using oral anticoagulants undergoing surgical procedures in dentistry: a systematic review and meta-analysis","volume":"10","author":"de Andrade","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib150","first-page":"21","article-title":"Efficacy of local tranexamic acid treatment for prevention of bleeding after dental procedures: a systematic review and meta-analysis","volume":"14","author":"Owattanapanich","year":"2019","journal-title":"J\u00a0Dent Sci"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib151","first-page":"756","article-title":"Cutaneous surgery in patients receiving warfarin therapy","volume":"27","author":"Alcalay","year":"2001","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib152","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1524-4725.1997.tb00065.x","article-title":"Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study","volume":"23","author":"Billingsley","year":"1997","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib153","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00266-002-2055-1","article-title":"Complications of minor cutaneous surgery in patients under anticoagulant treatment","volume":"26","author":"Kargi","year":"2002","journal-title":"Aesthetic Plast Surg"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib154","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jaad.2004.07.058","article-title":"A\u00a0prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery","volume":"51","author":"Syed","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0310057X0102900102","article-title":"Anticoagulation and cataract surgery: a review of the current literature","volume":"29","author":"Konstantatos","year":"2001","journal-title":"Anaesth Intensive Care"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib156","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41433-019-0382-6","article-title":"Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review","volume":"33","author":"Makuloluwa","year":"2019","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib157","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1744-6198.2006.00034.x","article-title":"A\u00a0study of the safety of continued anticoagulation for cataract surgery patients","volume":"41","author":"Hirschman","year":"2006","journal-title":"Nursing Forum"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib158","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/bja\/85.5.708","article-title":"Haemorrhage and risk factors associated with retrobulbar\/peribulbar block: a prospective study in 1383 patients","volume":"85","author":"Kallio","year":"2000","journal-title":"Br J Anaesth"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib159","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","article-title":"Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery","volume":"110","author":"Katz","year":"2003","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/112067219400400304","article-title":"Risk factors for intraoperative and early postoperative complications in extracapsular cataract surgery","volume":"4","author":"Lumme","year":"1994","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib161","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0886-3350(00)00887-7","article-title":"Effect of warfarin therapy on bleeding during cataract surgery","volume":"27","author":"Rotenstreich","year":"2001","journal-title":"J\u00a0Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib162","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0008-4182(06)80011-6","article-title":"Intraoperative eye position after sub-Tenon's anesthesia for cataract surgery","volume":"41","author":"Kumar","year":"2006","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib163","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/112067210601600106","article-title":"Cataract surgery under systemic anticoagulant therapy with coumarin","volume":"16","author":"Jonas","year":"2006","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib164","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajo.2007.07.029","article-title":"Phacoemulsification of cataract in patients receiving Coumadin therapy: ocular and hematologic risk assessment","volume":"144","author":"Barequet","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib165","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jcrs.2006.02.035","article-title":"Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel","volume":"32","author":"Kumar","year":"2006","journal-title":"J\u00a0Cataract Refract Surg"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib166","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bjo.73.9.702","article-title":"Warfarin and cataract extraction","volume":"73","author":"Robinson","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"22","key":"10.1016\/j.chest.2022.07.025_bib167","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib168","first-page":"1461","article-title":"Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies","volume":"19","author":"Proietti","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib169","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1160\/TH12-07-0498","article-title":"Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis","volume":"108","author":"Feng","year":"2012","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ahj.2009.06.005","article-title":"Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin","volume":"158","author":"Tischenko","year":"2009","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib171","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.thromres.2014.07.028","article-title":"Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial","volume":"134","author":"Schulman","year":"2014","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib172","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.ijcard.2013.06.022","article-title":"Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment\u2014the FinPAC study","volume":"168","author":"Airaksinen","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib173","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10840-019-00646-4","article-title":"Peri-procedural use of direct anticoagulation agents during cardiac device implantation: vitamin K antagonists vs\u00a0direct oral anticoagulants","volume":"58","author":"Pillarisetti","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib174","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-0026","article-title":"Continuous anticoagulation and cold snare polypectomy versus heparin bridging and hot snare polypectomy in patients on anticoagulants with subcentimeter polyps: a randomized controlled trial","volume":"171","author":"Takeuchi","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-8703(76)80251-7","article-title":"Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage","volume":"92","author":"Katholi","year":"1976","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib176","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(78)90080-7","article-title":"The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study","volume":"96","author":"Katholi","year":"1978","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib177","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-146-3-200702060-00007","article-title":"Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin","volume":"146","author":"O\u2019Donnell","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib178","first-page":"528","article-title":"Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery","volume":"94","author":"Douketis","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.chest.2022.07.025_bib179","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1538-7836.2007.02729.x","article-title":"Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT)","volume":"5","author":"Dunn","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib180","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1538-7836.2006.01908.x","article-title":"Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry","volume":"4","author":"Spyropoulos","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib181","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.amjcard.2005.05.028","article-title":"Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation","volume":"96","author":"Vink","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib182","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0049-3848(02)00387-0","article-title":"Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians","volume":"108","author":"Douketis","year":"2002","journal-title":"Thromb Res"},{"issue":"17","key":"10.1016\/j.chest.2022.07.025_bib183","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/heartjnl-2016-310581","article-title":"Perioperative management of anticoagulant and antiplatelet therapy","volume":"104","author":"Tafur","year":"2018","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib184","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AAP.0000000000000478","article-title":"Reply to Dr Lessire et\u00a0al","volume":"41","author":"Douketis","year":"2016","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCULATIONAHA.115.015688","article-title":"Perioperative management of dabigatran: a prospective cohort study","volume":"132","author":"Schulman","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib186","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/17512433.2021.1908124","article-title":"Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients","volume":"14","author":"Stollberger","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.chest.2022.07.025_bib187","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.thromres.2020.08.016","article-title":"Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review","volume":"194","author":"Li","year":"2020","journal-title":"Thromb Res"},{"issue":"19","key":"10.1016\/j.chest.2022.07.025_bib188","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2018.03.023","article-title":"Oral anticoagulation in patients with liver disease","volume":"71","author":"Qamar","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib189","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/AAP.0000000000000448","article-title":"Periprocedural management of direct oral anticoagulants should be guided by accurate laboratory tests","volume":"41","author":"Lessire","year":"2016","journal-title":"Reg Anesth Pain Med"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11739-018-1854-6","article-title":"The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures","volume":"13","author":"Tripodi","year":"2018","journal-title":"Intern Emerg Med"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib191","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/anae.15291","article-title":"Guideline for the management of hip fractures 2020: Guideline by the Association of Anaesthetists","volume":"76","author":"Griffiths","year":"2021","journal-title":"Anaesthesia"},{"issue":"suppl 1","key":"10.1016\/j.chest.2022.07.025_bib192","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ijlh.12658","article-title":"The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue","volume":"39","author":"Adcock","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib193","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2014.05.065","article-title":"Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants","volume":"64","author":"Cuker","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib194","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.accpm.2016.09.002","article-title":"Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP)\u2014September 2015","volume":"36","author":"Albaladejo","year":"2017","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib195","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib196","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib197","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/europace\/euw409","article-title":"Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial","volume":"19","author":"Essebag","year":"2017","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.chest.2022.07.025_bib198","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib199","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euy148","article-title":"Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events","volume":"21","author":"Nakamura","year":"2019","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.chest.2022.07.025_bib200","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/eurheartj\/ehy870","article-title":"When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study","volume":"40","author":"Yu","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib201","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","article-title":"A\u00a0prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial","volume":"4","author":"Reynolds","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib202","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s00417-019-04488-8","article-title":"Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs)","volume":"257","author":"Barequet","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.chest.2022.07.025_bib203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2021.04.006","article-title":"Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures","volume":"203","author":"Sheikh","year":"2021","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib204","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jth.13670","article-title":"Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease","volume":"15","author":"Shaw","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.chest.2022.07.025_bib205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/jth.14468","article-title":"Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: an analysis of thrombotic and bleeding outcomes","volume":"17","author":"Shaw","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"14","key":"10.1016\/j.chest.2022.07.025_bib206","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib207","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1055\/s-0040-1712476","article-title":"Periprocedural direct oral anticoagulant management: the RA-ACOD Prospective, Multicenter Real-World Registry","volume":"4","author":"Ferrandis","year":"2020","journal-title":"TH Open"},{"issue":"44","key":"10.1016\/j.chest.2022.07.025_bib208","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.chest.2022.07.025_bib209","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-017-0137-1","article-title":"Perioperative management of patients on direct oral anticoagulants","volume":"15","author":"Dubois","year":"2017","journal-title":"Thromb J"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/a-1715-5960","article-title":"Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper","volume":"122","author":"Squizzato","year":"2022","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib211","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/jth.13513","article-title":"To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply","volume":"14","author":"Tripodi","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib212","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/jth.13505","article-title":"To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment","volume":"14","author":"Spyropoulos","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"19","key":"10.1016\/j.chest.2022.07.025_bib213","article-title":"Predictors of bleeding in the perioperative anticoagulant use for surgery evaluation study","volume":"9","author":"Tafur","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.chest.2022.07.025_bib214","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/bloodadvances.2020002335","article-title":"Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure","volume":"4","author":"Shaw","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.chest.2022.07.025_bib216","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood-2018-04-791541","article-title":"Testing and monitoring direct oral anticoagulants","volume":"132","author":"Connors","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.chest.2022.07.025_bib217","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2018.11.009","article-title":"Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants","volume":"173","author":"Dager","year":"2019","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"10.1016\/j.chest.2022.07.025_bib218","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ijlh.12992","article-title":"An update on laboratory assessment for direct oral anticoagulants (DOACs)","volume":"41","author":"Gosselin","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib219","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib220","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal\u2014full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.chest.2022.07.025_bib221","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet\u00a0alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib222","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.thromres.2015.08.006","article-title":"Peri-procedural management of dabigatran and rivaroxaban: duration of anticoagulant discontinuation and drug concentrations","volume":"136","author":"Godier","year":"2015","journal-title":"Thromb Res"},{"issue":"14","key":"10.1016\/j.chest.2022.07.025_bib223","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/00003088-200443140-00002","article-title":"Avoidance of bleeding during surgery in patients receiving anticoagulant and\/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations","volume":"43","author":"Harder","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib224","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein","volume":"56","author":"Roth","year":"1975","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib225","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib226","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety","volume":"34","author":"Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib227","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40262-015-0290-2","article-title":"Ticagrelor: pharmacokinetic, pharmacodynamic and pharmacogenetic profile: an update","volume":"54","author":"Teng","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"15","key":"10.1016\/j.chest.2022.07.025_bib228","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","article-title":"Ticlopidine and clopidogrel","volume":"100","author":"Quinn","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib229","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1592\/phco.29.9.1089","article-title":"Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor","volume":"29","author":"Dobesh","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"19","key":"10.1016\/j.chest.2022.07.025_bib230","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.105.559088","volume":"112","author":"von Beckerath","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib231","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jacc.2004.08.060","article-title":"Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization","volume":"44","author":"Kandzari","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib232","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1345\/aph.10079","article-title":"Aggrenox: a fixed-dose combination of aspirin and dipyridamole","volume":"34","author":"Lenz","year":"2000","journal-title":"Ann Pharmacother"},{"issue":"suppl 2","key":"10.1016\/j.chest.2022.07.025_bib233","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1463-1326.2002.0040s2s14.x","article-title":"The pharmacology of cilostazol","volume":"4","author":"Schror","year":"2002","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib234","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/17425255.2017.1289175","article-title":"Pharmacokinetic drug evaluation of vorapaxar for secondary prevention after acute coronary syndrome","volume":"13","author":"Perez-Rivera","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 4","key":"10.1016\/j.chest.2022.07.025_bib236","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-198600324-00004","article-title":"Non-steroidal anti-inflammatory analgesics other than salicylates","volume":"32","author":"Brogden","year":"1986","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib237","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4174\/jkss.2013.85.4.185","article-title":"A\u00a0preliminary study: aspirin discontinuation before elective operations; when is the optimal timing?","volume":"85","author":"Gulpinar","year":"2013","journal-title":"J\u00a0Korean Surg Soc"},{"issue":"9212","key":"10.1016\/j.chest.2022.07.025_bib238","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib239","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/bja\/aeq003","article-title":"To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial","volume":"104","author":"Oscarsson","year":"2010","journal-title":"Br J Anaesth"},{"issue":"16","key":"10.1016\/j.chest.2022.07.025_bib240","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.chest.2022.07.025_bib241","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib242","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/bja\/aer274","article-title":"Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial","volume":"107","author":"Mantz","year":"2011","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib243","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejvs.2004.11.009","article-title":"Emboli rate during and early after carotid endarterectomy after a single preoperative dose of 120\u00a0mg acetylsalicylic acid\u2014a prospective double-blind placebo controlled randomised trial","volume":"29","author":"Tytgat","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib244","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00423-011-0867-7","article-title":"A\u00a0randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery\u2014the APAP trial (ISRCTN45810007)","volume":"397","author":"Antolovic","year":"2012","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40199-016-0159-4","article-title":"Aspirin use and bleeding volume in skin cancer patients undergoing surgery: a randomized controlled trial","volume":"24","author":"Engheta","year":"2016","journal-title":"Daru"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib246","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ccd.20124","article-title":"Major noncardiac surgery following coronary stenting: when is it safe to operate?","volume":"63","author":"Sharma","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib247","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjcard.2004.11.029","article-title":"Risks of noncardiac surgery after coronary stenting","volume":"95","author":"Reddy","year":"2005","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib248","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.129.3.734","article-title":"Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans","volume":"129","author":"Ernst","year":"2006","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib249","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0003-4975(00)02133-0","article-title":"Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients","volume":"70","author":"Dacey","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib250","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2007.10.003","article-title":"Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial: rationale and design","volume":"155","author":"Myles","year":"2008","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib251","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2006.04.029","article-title":"Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery","volume":"48","author":"Mehta","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.chest.2022.07.025_bib252","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib253","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/hrt.2004.058396","article-title":"Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis","volume":"92","author":"Purkayastha","year":"2006","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib254","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0735-1097(02)01954-X","article-title":"The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting","volume":"40","author":"Hongo","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib255","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2004.02.019","article-title":"Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting","volume":"128","author":"Chen","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib256","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib257","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1016\/j.jtcvs.2014.04.054","article-title":"Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis","volume":"148","author":"Cao","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib258","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5455\/medarh.2015.69.381-383","article-title":"Does early post-operative administration of aspirin influence the risk of bleeding after coronary artery bypass graft surgery? A prospective observational study","volume":"69","author":"Nouraei","year":"2015","journal-title":"Med Arch"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib259","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1373\/clinchem.2004.047050","article-title":"Monitoring of clopidogrel action: comparison of methods","volume":"51","author":"Geiger","year":"2005","journal-title":"Clin Chem"},{"issue":"21","key":"10.1016\/j.chest.2022.07.025_bib260","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.103.21.2572","article-title":"Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study","volume":"103","author":"Steinhubl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.chest.2022.07.025_bib261","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2015.02.023","article-title":"An observational study investigating the effect of platelet function on outcome after colorectal surgery","volume":"17","author":"Keeler","year":"2015","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib262","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2008-1066028","article-title":"Can we predict bleeding?","volume":"34","author":"Watson","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"suppl 3","key":"10.1016\/j.chest.2022.07.025_bib263","doi-asserted-by":"crossref","first-page":"35A","DOI":"10.1016\/j.amjcard.2008.11.022","article-title":"Monitoring platelet function to reduce the risk of ischemic and bleeding complications","volume":"103","author":"Price","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib264","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ALN.0b013e318186ddf8","article-title":"Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention","volume":"109","author":"Nuttall","year":"2008","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib265","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/ALN.0b013e318186de1c","article-title":"Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents","volume":"109","author":"Rabbitts","year":"2008","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib266","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jhm.227","article-title":"Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study","volume":"2","author":"Brotman","year":"2007","journal-title":"J\u00a0Hosp Med"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib267","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.amjcard.2006.05.050","article-title":"Risk of noncardiac surgery after coronary drug-eluting stent implantation","volume":"98","author":"Compton","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib268","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2006.10.004","article-title":"Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events","volume":"49","author":"Schouten","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib269","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcin.2009.03.014","article-title":"Characterization of post-operative risk associated with prior drug-eluting stent use","volume":"2","author":"Anwaruddin","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/M17-2341","article-title":"Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery","volume":"168","author":"Graham","year":"2018","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.chest.2022.07.025_bib271","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","article-title":"Non-cardiac surgery in patients with coronary stents: the RECO study","volume":"97","author":"Albaladejo","year":"2011","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib272","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bja.2017.11.012","article-title":"Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery: association with adverse events","volume":"120","author":"Rodriguez","year":"2018","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib273","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13643-017-0635-z","article-title":"Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review","volume":"7","author":"Childers","year":"2018","journal-title":"Syst Rev"},{"issue":"25","key":"10.1016\/j.chest.2022.07.025_bib274","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.jacc.2014.09.072","article-title":"The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting","volume":"64","author":"Holcomb","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.chest.2022.07.025_bib275","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","article-title":"Risk associated with surgery within 12\u00a0months after coronary drug-eluting stent implantation","volume":"68","author":"Egholm","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.chest.2022.07.025_bib276","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2017.10.051","article-title":"A\u00a0multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2","volume":"11","author":"Rossini","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib277","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1532\/HSF98.20121103","article-title":"Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery","volume":"16","author":"Firstenberg","year":"2013","journal-title":"Heart Surg Forum"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib278","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib279","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2169\/internalmedicine.55.5495","article-title":"Unfractionated heparin during the interruption of antiplatelet therapy for non-cardiac surgery after drug-eluting stent implantation","volume":"55","author":"Tanaka","year":"2016","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2022.07.025_bib280","first-page":"423","article-title":"Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery","volume":"114","author":"Capodanno","year":"2015","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib281","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of \u2018bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"issue":"11","key":"10.1016\/j.chest.2022.07.025_bib282","first-page":"1313","article-title":"Use of eptifibatide in patients with acute stent thrombosis, requiring urgent surgical revascularisation\u2014report of 2 cases [in Polish]","volume":"67","author":"Wilczynski","year":"2009","journal-title":"Kardiol Pol"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib283","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.carrev.2018.11.018","article-title":"Intravenous antiplatelet therapy bridging in patients undergoing cardiac or non-cardiac surgery following percutaneous coronary intervention","volume":"20","author":"Dargham","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.chest.2022.07.025_bib284","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vph.2015.11.085","article-title":"Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: analysis of 314 patients","volume":"80","author":"De Servi","year":"2016","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib285","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/phar.1956","article-title":"Bridging with tirofiban during oral antiplatelet interruption: a single-center case series analysis including patients on hemodialysis","volume":"37","author":"Walker","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib286","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14219\/jada.archive.2000.0176","article-title":"Does low-dose aspirin therapy complicate oral surgical procedures?","volume":"131","author":"Ardekian","year":"2000","journal-title":"J\u00a0Am Dent Assoc"},{"issue":"8","key":"10.1016\/j.chest.2022.07.025_bib287","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/154405910808700814","article-title":"Aspirin use and post-operative bleeding from dental extractions","volume":"87","author":"Brennan","year":"2008","journal-title":"J\u00a0Dental Res"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib288","doi-asserted-by":"crossref","first-page":"690","DOI":"10.14219\/jada.archive.2009.0255","article-title":"The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy","volume":"140","author":"Napenas","year":"2009","journal-title":"J\u00a0Am Dental Assoc"},{"issue":"9","key":"10.1016\/j.chest.2022.07.025_bib289","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.joms.2005.05.164","article-title":"Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients","volume":"63","author":"Madan","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.chest.2022.07.025_bib290","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.joms.2011.02.139","article-title":"Bleeding evaluation during single tooth extraction in patients with coronary artery disease and acetylsalicylic acid therapy suspension: a prospective, double-blinded, and randomized study","volume":"69","author":"Medeiros","year":"2011","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib291","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1054\/bjps.1999.3082","article-title":"Does aspirin affect the outcome of minor cutaneous surgery?","volume":"52","author":"Bartlett","year":"1999","journal-title":"Br J Plast Surg"},{"issue":"3","key":"10.1016\/j.chest.2022.07.025_bib292","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.SAP.0000037275.54751.4E","article-title":"Outcome of aspirin use during excision of cutaneous lesions","volume":"50","author":"Shalom","year":"2003","journal-title":"Ann Plast Surg"},{"issue":"1","key":"10.1016\/j.chest.2022.07.025_bib293","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1600-0420.2003.00020.x","article-title":"The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery","volume":"81","author":"Narendran","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"10.1016\/j.chest.2022.07.025_bib294","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IOP.0000000000001652","article-title":"Effects of aspirin on postoperative bruising and bleeding complications in upper eyelid surgery","volume":"36","author":"Winkler","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.chest.2022.07.025_bib295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bjps.2017.11.024","article-title":"Bleeding on the cutting edge: a systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery","volume":"71","author":"Isted","year":"2018","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"}],"updated-by":[{"DOI":"10.1016\/j.chest.2023.05.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222013599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222013599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T20:36:22Z","timestamp":1688589382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222013599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":295,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0012369222013599"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.07.025","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Management of Antithrombotic Therapy","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.08.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}